Clinical Biochemistry Laboratory, City of Health and Science University Hospital, Turin, Italy.
Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, City of Health and Science University Hospital, University of Turin, Turin, Italy.
Anal Chim Acta. 2021 May 22;1160:338455. doi: 10.1016/j.aca.2021.338455. Epub 2021 Mar 27.
Total Value of Ownership (TVO) and Overall Equipment Effectiveness (OEE) analysis are novel tools capable of monitoring and analyzing industrial processes by assessing the efficiency of the entire instrumental equipment and calculating instrument capacity utilization. Such integrated analysis, measuring quality indicators of the testing process, could also provide new perspectives and methodologies for the workflow organization of clinical laboratories. In this study, TVO and OEE were employed for the evaluation of two different configurations of a therapeutic drug monitoring sector, comparing the results obtained for immunosuppressant (ISD) and anti-epileptic drugs (AED) analysis as well as checking their quantitative performance in terms of limit of quantification, accuracy and precision. TVO analysis was performed for ISDs, including the Total Direct Labor Time, Total Cycle Time and Turnaround Time as well as cost of testing. Instruments' performance and workload were assessed using OEE indicator, studying Availability, Performance and Quality factors. Total Cycle Time for a batch was 3.55 h, decreasing of 1.5 h in the new setting where personnel are engaged for 0.98 h, 25% of total testing time. The calculated cost per sample was 6.60 euro. Availability values were significantly higher for automated sample-handling system and ISDs analysis by LC-MS. Higher Performance values were obtained for LC-MS system for AED and other TDM. Quality values were >0.94 for all instruments. TVO and OEE proved to be applicable to clinical laboratory environment, quantifying benefits and costs of newly developed semi-automated therapeutic drug monitoring sector. This novel approach based on an integrated analysis may help activity planning and quality improvement and could be used in the future for benchmarking progress as a product/process comparison tool in other laboratory fields.
全生命周期成本(TVO)和整体设备效率(OEE)分析是一种新颖的工具,能够通过评估整个仪器设备的效率并计算仪器容量利用率来监测和分析工业过程。这种综合分析,测量测试过程的质量指标,也可以为临床实验室的工作流程组织提供新的视角和方法。在这项研究中,TVO 和 OEE 用于评估治疗药物监测领域的两种不同配置,比较免疫抑制剂(ISD)和抗癫痫药物(AED)分析的结果,并检查它们在定量性能方面的检测限、准确性和精密度。对 ISD 进行了 TVO 分析,包括总直接人工时间、总周期时间和周转时间以及测试成本。使用 OEE 指标评估仪器的性能和工作量,研究可用性、性能和质量因素。批量的总周期时间为 3.55 小时,在新设置中减少了 1.5 小时,其中人员的工作时间为 0.98 小时,占总测试时间的 25%。每个样本的计算成本为 6.60 欧元。自动化样本处理系统和 LC-MS 分析的可用性值明显更高。对于 LC-MS 系统,AED 和其他 TDM 的性能值更高。所有仪器的质量值均>0.94。TVO 和 OEE 被证明适用于临床实验室环境,量化了新开发的半自动治疗药物监测领域的收益和成本。这种基于综合分析的新方法可以帮助活动计划和质量改进,并可在未来用于作为其他实验室领域的产品/过程比较工具来基准进度。